Transcription of LENALIDOMIDE WITH DEXAMETHASONE - Haematology
{{id}} {{{paragraph}}}
Example: air traffic controller
LENALIDOMIDE WITH DEXAMETHASONE - Haematology
Myeloma group This is a controlled document and therefore must not be changed MM. 18 Len wi th Dex Authorised by Myeloma lead Dr. Karthik Ramasamy June 2021 V. 1 of 8 LENALIDOMIDE WITH DEXAMETHASONE INDICATION 1. Newly diagnosed myeloma in patients considered ineligible for stem cell transplant. Bluteq approval is required 2. Newly diagnosed myeloma patients eligible for stem cell transplant, in preference to regimens that need more hospital attendances and parenteral administrations to reduce toxicity of treatment and number of admissions needed for treatment. COVID Blueteq approval is required.
o Thyroid Function. o Baseline random blood glucose level ... the use of G-CSF and platelet support should be considered. Recommended dose adjustments during treatment and to restart treatment: Dose adjustments, as summarised below, are recommended to manage grade 3 or 4 neutropenia or ... according to standard guidelines ...
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: